The European Commission has awarded a CE Mark for Medasense Biometrics’ pain monitoring device, PMD200.
This device allows post-operative care units to adjust the treatment of pain by avoiding the use of excess or deficiency of analgesics that may cause major complication.
The system consists of a finger probe that receives and measures physiological signals from four different sensors. This data is then analyzed by algorithms and converted to reflect a pain index score. — Cynthia Jessup